| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/01/2005 | US6849450 Antibodies to the metalloproteinase inhibitor |
| 02/01/2005 | US6849448 Pigs and pig cells having an inactivated α 1,3-galactosyl transferase gene |
| 02/01/2005 | US6849438 Isolated and purified human soluble guanylyl cyclase α1/β1 (hsgcα1/β1) |
| 02/01/2005 | US6849436 Nucleotide sequences coding polypeptide for use in the treatment of blood disorders, gout, kidney stones, Lesch-Nyhan syndrome, renal failure and uricaciduria |
| 02/01/2005 | US6849431 Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus |
| 02/01/2005 | US6849425 Conferring donor complementary determining region binding affinity onto an antibody acceptor variable region framework |
| 02/01/2005 | US6849421 Nucleotide sequences coding enzymatic polypeptide for the use in the treatment of nervous system disorders |
| 02/01/2005 | US6849420 Isolated autophosphorylating polypeptide, possessing PI3 kinase (phosphoinositide-3 kinase) activity; use drug screening for regulators of cell motility, such as antimetastasis agents |
| 02/01/2005 | US6849419 Monoclonal antibody hybridoma immunoassay method and diagnosis kit |
| 02/01/2005 | US6849416 Immunoglobulin for use in diagnosis of nervous system and psychological disorders |
| 02/01/2005 | US6849413 Comprises peptidoglycan recognition protein (PGRP) for diagnosis and treatment of blood and tumor disorders |
| 02/01/2005 | US6849260 Methods and compositions for treating IgE-related disease using NNT-1 inhibitors |
| 02/01/2005 | US6849259 Polyclonal antibody composition for treating allergy |
| 02/01/2005 | US6849258 Humanized, produced by the cell line deposited as ATCC HB 11423; prevents or inhibits graft rejection, graft versus host disease or autoimmune disease. |
| 02/01/2005 | CA2436349A1 The selective mmp-9-inhibitor rega-3g12scfv ameliorates in vivo parameters of kidney function after renal ischemia |
| 02/01/2005 | CA2248140C Assay and reagents for quantifying hbnp |
| 02/01/2005 | CA2094261C Polypeptide of a growth factor receptor family, application in the diagnosis and treatment of myeloproliferative diseases |
| 01/28/2005 | CA2469094A1 Methods for diagnosis and therapy of cancer and composition useful therein |
| 01/27/2005 | WO2005008246A1 In vitro diagnosis method for early detection of cervical dysplasias and cancer, associated with hpv |
| 01/27/2005 | WO2005007889A1 Method for diagnosing colorectal cancers |
| 01/27/2005 | WO2005007851A1 The dna-antibody and the uses thereof |
| 01/27/2005 | WO2005007844A1 Method of screening for agents that modulate immunophilin/peptidylproline cis-trans isomerase (ppiase)-homer interaction |
| 01/27/2005 | WO2005007836A1 Regulatory t-cells containing galectins for the therapy and diagnosis of diseases |
| 01/27/2005 | WO2005007809A2 Antibodies and fusion proteins that include engineered constant regions |
| 01/27/2005 | WO2005007804A2 Anthrax conjugate vaccine and antibodies |
| 01/27/2005 | WO2005007800A2 Monoclonal antibody against platelet membrane glycoprotein vi |
| 01/27/2005 | WO2005007701A1 Intensified fusion protein fv-ldp-ae having angiogenesis inhibiting and antitumor activety and the use thereof |
| 01/27/2005 | WO2005007700A1 Antibodies to cd44 vra and methods of use |
| 01/27/2005 | WO2005007699A2 Human antibody molecules for il-13 |
| 01/27/2005 | WO2005007698A1 Monoclonal antibody against influenza b virus and immunoassay instrument using the antibody |
| 01/27/2005 | WO2005007697A1 Anti-influenza type a virus monoclonal antibody and immunoassay instrument using the antibody |
| 01/27/2005 | WO2005007696A2 Humanized immunoglobulin loci |
| 01/27/2005 | WO2005007695A2 Anti-cd63 antibodies and methods of use thereof |
| 01/27/2005 | WO2005007692A1 Antibodies that recognize the brms1 protein and uses thereof |
| 01/27/2005 | WO2005007690A1 Recombinant expression of streptococcus pyogenes cysteine protease and immunogenic compositions thereof |
| 01/27/2005 | WO2005007674A2 Anti-human vitronectin antibody and methods for making the same |
| 01/27/2005 | WO2005007671A2 Compositions and methods for treating sars |
| 01/27/2005 | WO2005007198A2 Design of disease specific agents for diagnostics and therapeutics based on the protein isoform of vegf, her-2, psa |
| 01/27/2005 | WO2005007190A1 Agonists or antagonists of the clucocorticoid-induced tumour necrosis factor receptor (gitr) or its ligand for the treatment of immune disorders, infections and cancer |
| 01/27/2005 | WO2005007189A1 Subunit vaccine against respiratory syncytial virus infection |
| 01/27/2005 | WO2005006864A1 Genetic vaccines for cancer therapy |
| 01/27/2005 | WO2004102198A3 Selection of b cells with specificity of interest: method of preparation and use |
| 01/27/2005 | WO2004081026A3 Polypeptides |
| 01/27/2005 | WO2004074514A3 Method of diagnosis of type 2 diabetes and early onset thereof |
| 01/27/2005 | WO2004074325A3 Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers |
| 01/27/2005 | WO2004067707A3 Administration of transposon-based vectors to reproductive organs |
| 01/27/2005 | WO2004064740A3 Sperm specific lysozyme-like proteins |
| 01/27/2005 | WO2004060041A3 Kim-1 antagonists and use to modulate immune system |
| 01/27/2005 | WO2004050851A3 Prion protein ligands and methods of use |
| 01/27/2005 | WO2004039952A8 Methods of use for novel human polypeptides encoded by polynucleotides |
| 01/27/2005 | WO2004038002A3 Modulation of dendritic cell function and other cellular responses mediated by defensin compositions |
| 01/27/2005 | WO2003087374A9 Derivatives of the il-2 receptor gamma chain, their production and use. |
| 01/27/2005 | WO2002042417A3 Human erg2 potassium channel |
| 01/27/2005 | US20050022257 Transgenic animals harboring appallele having swedish mutation |
| 01/27/2005 | US20050020813 Streptococcus pneumoniae proteins and nucleic acids |
| 01/27/2005 | US20050020812 A chromatography media such as silica controlled pore glass or agarose containing an affinity ligand such as 2-Aminobenzimidazole (ABI) or aminomethylbenzimidazole (AMBI); great degree of selectivity, particularly towards proteins such as IgG |
| 01/27/2005 | US20050020497 Mammalian glycoprotein hormone-1 |
| 01/27/2005 | US20050019889 Human osteoclast derived cathepsin |
| 01/27/2005 | US20050019872 PC-LECTIN protein; vaccines and diagnostic marker for prostate cancer |
| 01/27/2005 | US20050019866 Nucleotide sequences coding membrane protein for use in diagnosis, detection, prevention and/or treatment of cell proliferative disorders |
| 01/27/2005 | US20050019858 Novel human cytokine/steroid receptor protein |
| 01/27/2005 | US20050019847 Using preferential antibodies to identify ubiquitin-like protein (ISG15); immunodiagnostics; wound healing agents |
| 01/27/2005 | US20050019845 Immunoconjugates of antibodies and cytotoxic agents (ricin, taxol); for treament of cancer and metastasis; tomography |
| 01/27/2005 | US20050019839 Secretions of proteins by encapsulated cells |
| 01/27/2005 | US20050019833 Proteins capable of binding to environmental hormones and process for producing the same |
| 01/27/2005 | US20050019824 Fibroblast Growth Factor-10 |
| 01/27/2005 | US20050019823 Using enhanced concentration of transmembrane polypeptide as diagnostic indicator of cell proliferative disorers; diagnosing cancer; antitumor agents |
| 01/27/2005 | US20050019821 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/27/2005 | US20050019812 Neutral amino acid transporter and gene thereof |
| 01/27/2005 | US20050019811 Neutral amino acid transporter and gene thereof |
| 01/27/2005 | US20050019780 Transforming cells with vector comprising nucleotide sequences coding membrane protein for use in identifying modulators for treatment of metabolic disorders; transmembrane traps; immunodiagnostics |
| 01/27/2005 | US20050019768 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 01/27/2005 | US20050019763 Isolated polypeptide of given sequence; expression vectors, host cells, antibodies, agonists, and antagonists; use in diagnosing, treating, or preventing various disorders |
| 01/27/2005 | US20050019758 Reactive with F protein epitope of Respiratory Syncytial Virus and capable of neutralizing infection; use in prophylactic immunotherapy |
| 01/27/2005 | US20050019343 administering an effective dose of a polypeptide comprising an immunogenic fragment of A beta (SEQ ID NO:1) and an adjuvant in a regime effective to induce an immune response comprising antibodies to the A beta fragment; Alzheimer's disease |
| 01/27/2005 | US20050019334 Interleukin antibody or fusion protein; comprising active material and FC domain; Escherichia coli cells |
| 01/27/2005 | US20050019333 Glycosylated specificity exchangers |
| 01/27/2005 | US20050019332 Laminin chains: diagnostic uses |
| 01/27/2005 | US20050019330 administering an antibody that specifically binds to the amyloid deposit or a component thereof; can be a human, humanized, chimeric or nonhuman antibody and can be monoclonal or polyclonal; also a novel monoclonal antibody which specifically binds to an epitope within residues 13-28 of A beta |
| 01/27/2005 | US20050019328 Prevention and treatment of amyloidogenic disease |
| 01/27/2005 | US20050019327 Monoclonal antibodies to hepatocyte growth factor |
| 01/27/2005 | US20050019326 Antiinflammatory agents; tissue injury; autoimmune disease; anticancer agents |
| 01/27/2005 | US20050019324 Peptides and antibodies to muc 1 proteins |
| 01/27/2005 | US20050019323 Treatment of Crohn's disease or psoriasis using anti-interferon gamma antibodies |
| 01/27/2005 | US20050019322 Treatment of central nervous system diseases by antibodies against glatiramer acetate |
| 01/27/2005 | US20050019321 Method of obtaining protection against bystander allergen |
| 01/27/2005 | US20050019305 Inhibiting ligand/receptor interactions involving immunoglobulins, interleukins, interferon-alpha, histamine and/or leukotrienes; long term relief; kits |
| 01/27/2005 | CA2805464A1 Human antibody molecules for il-13 |
| 01/27/2005 | CA2804901A1 Human antibody molecules for il-13 |
| 01/27/2005 | CA2537896A1 East coast fever vaccine based on ctl-specific schizont antigens |
| 01/27/2005 | CA2532781A1 The anti-platelet membrane glycoprotein vi monoclonal antibody |
| 01/27/2005 | CA2532323A1 Antibodies to cd44 vra and methods of use |
| 01/27/2005 | CA2532164A1 Subunit vaccine against respiratory syncytial virus infection |
| 01/27/2005 | CA2532127A1 Regulatory t-cells containing galectins for the therapy and diagnosis of diseases |
| 01/27/2005 | CA2531393A1 Recombinant expression of streptococcus pyogenes cysteine protease and immunogenic compositions thereof |
| 01/27/2005 | CA2527878A1 Antibodies and fusion proteins that include engineered constant regions |
| 01/26/2005 | EP1500934A1 A method for determining a risk of atherosclerosis or future development of atherosclerotic complications |
| 01/26/2005 | EP1500702A1 APO-2LI and APO-3 apoptosis polypeptides from the TNFR1 familiy |
| 01/26/2005 | EP1500701A1 Cancer-associated gene mina 53, protein mina 53 and monoclonal antibody thereof |
| 01/26/2005 | EP1500698A1 Cell with depression or deletion of the activity of protein participating in gdp-fucose transport |